Subendothelial proteoglycan synthesis and transforming growth factor beta distribution correlate with susceptibility to atherosclerosis

Journal of Vascular Research

Volumn 34, Issue 5, 1997, Pages 365-377

  Scott, Lesley ^a   Kerr, Alan ^b   Haydock, David ^b   Merrilees, Mervyn ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b GREEN LANE HOSPITAL   (New Zealand)

Author keywords

Atherosclerosis; Coronary arteries; Coronary bypass; Internal thoracic artery; Proteoglycans; Saphenous vein; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY; DISEASE PREDISPOSITION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNAL MAMMARY ARTERY; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; SAPHENOUS VEIN; SUBENDOTHELIUM;

AGED; ANTIBODIES; ARTERIOSCLEROSIS; DISEASE SUSCEPTIBILITY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; ORGAN CULTURE TECHNIQUES; PROTEOGLYCANS; SAPHENOUS VEIN; THORACIC ARTERIES; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030823540     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159245     Document Type: Article

References (43)

1. Bashour TT, Hanna ES, Mason DT: Myocardial revascularisation with internal mammary artery bypass: An emerging treatment of choice. Am HeartJ 1986:111:143-151.
2. Sons HJ, Godchardt E, Kunert J, Lossc B, Bircks W: Internal thoracic artery: Prevalence of atherosclerotic changes. J Thorac Cardio-vascSurg 1993;106:1192-1195.
3. Soyombo AA, Angelini GD, Bryan AJ, Newby AC: Surgical preparation induces injury and promotes smooth muscle cell proliferation in a culture of human saphenous vein. Cardiovasc Res 1993;27:1961-1967.
4. Paz MA, Lupon J, Bosch X, Pomar JL, Sanz G, GESIC Study Group: Predictors of early saphenous vein aortocoronary bypass graft occlusion. Ann Thorac Surg 1993,56:1101-1106.
5. Nwasokwa ON: Coronary artery bypass graft disease. Ann Intern Med 1995;123:528-545.
6. Sims FH: The internal mammary artery as a bypass graft? Ann Thorac Surg 1987;44:2-3.
7. Mcrrilees MJ, Shepphard AJ, Robinson MC: Structural features of saphenous vein and internal thoracic artery endothelium: Correlates with susceptibility and resistance to graft atherosclerosis. J Cardiovasc Surg 1988;29:639-646.
8. Chaux A, Ruan XM, Fishbcin MC, Sandhu M, Matloff JM: Influence of vein valves in the development of arteriosclerosis in venoarterial grafts in the rabbit. J Thorac Cardiovasc Surg 1995;110:1381-1390.
9. Sisto T, Yla-Herttuala S, Luoma J, Riekkinen H, Nikkari T: Biochemical composition of human internal mammary artery and saphenous vein. J Vase Surg 1990;11:418-422.
10. Iverius PH: The interaction between human plasma lipoproteins and connective tissue glv-cosaminoglycans. J Biol Chem 1972:247:2607.
11. Williams KJ, Tabas I: The response-to-reten-lion hypothesis in early athcrogencsis. Artcr-ioscier Thromb Vase Biol 1995; 15:551-561.
12. Galis ZS, Alavi MZ, Moore S: Co-localisation of aortic apolipoprotein B and chondroitin sulfate in an injury model of atherosclerosis. Am J Pathol 1993;142:1432-1438.
13. Camejo G, Olofsson S-V, Lopez F, Carlsson P, Bonjers G: Idcntifiaction of Apo-BlOO segments mediating the interaction of low density lipoproteins with arterial proteoglycans. Arteriosclerosis 1988;8:368-377.
14. Srinivasan SR, Radhakrishnamurthy B, Dalfercs DR, Berenson GS: Collagenase-solubil-ised lipoprotein-GAG complexes of human aortic fibrous plaque lesions. Arthcrosclerosis 1979;34:105-118.
15. Schwenke DC, Carcw TE: Initiation of athero-sclerotis lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis 1989;9:895-907.
16. Schwenke DC, Carcw TE: Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL versus selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 1989:9:908-918.
17. Schwenke DC, St Clair RW: Influx, efflux, and accumulation of LDL in normal arterial areas and atherosclerotic lesions of white cameau pigeons with naturally occurring and cholesterol-aggravated aortic atherosclerosis. Artcrio-scler Thromb 1993;13:1368-1381.
18. Chcrchi GM, Coinu R, Demuro P, Formato M, Sanna G, Tidore M, Tira ME, De Luca G: Structural and functional modifications of human aorta proteoglycans in atherosclerosis. Matrix 1990;10:362-372.
19. 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 1991;266:17640-17647.
20. Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, Ahlstrom C, Fager G, Bondjers G: Effect of arterial proteoglycans and glycosaminogly-cans on low density lipoprotein oxidation and its uptake by human macrophages and smooth muscle cells. Arterioscler Thromb 1992; 12: 569-583.
21. Vijayagopal P, Srinivasan SR, Xu J-H, Dalferes ER, Radhakrishnamurthy B, Berenson GS: Lipoprotein-proteoglycan complexes induce continued cholcsteryl ester accumulation in foam cells from rabbit atherosclerotic lesions. J Clin Invest 1993;91:1011-1018.
22. Srinivasan SR, Xu J-H, Vijayagopal P, Radhakrishnamurthy B, Berenson GS: Low-density lipoprotein binding affinity of arterial chondroitin sulfate proteoglycan variants modulates cholesteryl ester accumulation in macrophages. Biochim Biophvs Acta 1995;1272:61-67.
23. Stary HC: The sequence of cell and matrix changes in atherosclerotic lesions of coronary artenes in the first forty years of life. Eur Heart J 1990:11(suppl E):3-19.
24. 1. Vase Res 1993;30:293-302.
25. Watsy F, Alavi MZ, Moore S: Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mcllitus. Diabetes 1993;36:316-322.
26. Wight TN: Chapter 7. Arterial wall; in Comper WD (ed): Extracellular Matrix, vol 1. Tissue Function. New York. Harwood Academic Publishers, 1996, pp 175-202.
27. 1 inhibits proteoglycan synthesis in arterial wall. J Vase Res 1994;31:322-329.
28. 1 is increased in human vascular restenosis lesions. J Clin Invest 1992:90: 1582-1592.
29. 1 during repair of arterial injury. J Clin Invest 1991;88:904-910.
30. Schmike R: Methods for analysis of enzyme synthesis and degradation in animal tissues. Methods Enzymol 1975:40:241-266.
31. Merrilccs MJ, Merrilees MA, Bimbaum PS, Scott PJ, Flint MH: The effect of centrifugal force on glycosaminoglycan production by aortic smooth muscle cells in culture. Atherosclerosis 1977:27:259-264.
32. Rogers KM, Merrilees MJ, Stehbens WE: The effect of haemodynamic stress on the glycosaminoglycan content of blood vessel walls of experimental aneurysms and arteriovenous fis-tulae. Atherosclerosis 1985;58:139-148.
33. 1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats. Hypertension 1991;17:896-901.
34. 1 by vascular endothelial cells is correlated with cell spreading. J Vase Res 1992,29:376-384.
35. Chen J-K, Hoshi H, McKcehan WL: Trans-forminggrowth factor type β specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. PNAS 1987:84: 5287-5291.
36. Merrilees MJ, Scott LJ: Endothelial cell stimulation of smooth muscle glycosaminoglycan synthesis can be accounted for by transforming growth factor beta activity. Atherosclerosis 1990;81:255-265.
37. 1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vase Biol 1995;15:1951-1957.
38. 1 suppress intimal hyperplasia in rat model. J Clin Invest 1994:93:1172-1178.
39. Grainger DJ, Metcalfe JC: A pivotal role for TGF-b in atherogenesis. Biol Rev 1995:70: 571-596.
40. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A: The serum concentration of active transforming growth factor beta is severely depressed in advanced atherosclerosis. Nature Med 1995:174-179.
41. Spom MB, Roberts AB: Transforming growth factor-β: Multiple actions and potential clinical applications. JAMA 1989:262:938-941.
42. Bassols A, Massague J: Transforming growth factor-β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem 1988:263: 3039-3045.
43. Kahari V-M, Larjava H, Uitto J: Differential regulation of extracellular matrix proteoglycan (PG) gene expression. J Biol Chem 1991:266: 10608-10615.